lecanemab-irmb 360 MG per 1.8 ML Auto-Injector

RxCUI: 2723406
RxNorm name: lecanemab-irmb 360 MG per 1.8 ML Auto-Injector
Display name: lecanemab-irmb 360 MG per 1.8 ML Auto-Injector
Full name: lecanemab-irmb 360 MG per 1.8 ML Auto-Injector
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:39:10

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
761269	Leqembi	lecanemab-irmb	351(a)	Rx	2026-06-01
761375	Leqembi IQLIK	lecanemab-irmb	351(a)	Rx	2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
LEQEMBI	LECANEMAB	Eisai Inc.	9d1ff786-e577-410a-a273-c4d7d0e4e975	2026-07-21	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 2723406

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
9d1ff786-e577-410a-a273-c4d7d0e4e975	lecanemab-irmb 360 MG per 1.8 ML Auto-Injector	SY	22	These highlights do not include all the information needed to use LEQEMBI ® safely and effectively. See full prescribing information for LEQEMBI ® . LEQEMBI ® (lecanemab-irmb) injection, for intravenous or subcutaneous use Initial U.S. Approval: 2023	20260123
9d1ff786-e577-410a-a273-c4d7d0e4e975	lecanemab-irmb 360 MG in 1.8 ML Auto-Injector	PSN	22	These highlights do not include all the information needed to use LEQEMBI ® safely and effectively. See full prescribing information for LEQEMBI ® . LEQEMBI ® (lecanemab-irmb) injection, for intravenous or subcutaneous use Initial U.S. Approval: 2023	20260123
9d1ff786-e577-410a-a273-c4d7d0e4e975	1.8 ML lecanemab-irmb 200 MG/ML Auto-Injector	SCD	22	These highlights do not include all the information needed to use LEQEMBI ® safely and effectively. See full prescribing information for LEQEMBI ® . LEQEMBI ® (lecanemab-irmb) injection, for intravenous or subcutaneous use Initial U.S. Approval: 2023	20260123